Semmes E, Li S, Hurst J, Yang Z, Niedzwiecki D, Fouda G
Clin Infect Dis. 2021; 74(7):1131-1140.
PMID: 34260701
PMC: 8994583.
DOI: 10.1093/cid/ciab627.
Stockdale L, Nash S, Nalwoga A, Gibson L, Painter H, Raynes J
Trop Med Int Health. 2018; 24(2):247-257.
PMID: 30506614
PMC: 6378403.
DOI: 10.1111/tmi.13188.
Getahun A, Smith M, Kogut I, van Dyk L, Cambier J
J Immunol. 2012; 189(6):2965-74.
PMID: 22904300
PMC: 3436999.
DOI: 10.4049/jimmunol.1201407.
Varani S, Landini M
Herpesviridae. 2011; 2(1):6.
PMID: 21473750
PMC: 3082217.
DOI: 10.1186/2042-4280-2-6.
Flano E, Woodland D, Blackman M
Immunol Res. 2002; 25(3):201-17.
PMID: 12018460
DOI: 10.1385/IR:25:3:201.
Blood and alveolar lymphocyte subsets in pulmonary cytomegalovirus infection after lung transplantation.
Stephan F, Bernaudin J, Cesari D, Fajac A, Grenet D D, Caubarrere I
BMC Infect Dis. 2001; 1:15.
PMID: 11602020
PMC: 57810.
DOI: 10.1186/1471-2334-1-15.
Non-antigen-specific B-cell activation following murine gammaherpesvirus infection is CD4 independent in vitro but CD4 dependent in vivo.
Stevenson P, Doherty P
J Virol. 1999; 73(2):1075-9.
PMID: 9882308
PMC: 103927.
DOI: 10.1128/JVI.73.2.1075-1079.1999.
B-cell activation following murine cytomegalovirus infection: implications for autoimmunity.
Price P, Olver S, Gibbons A, Shellam G
Immunology. 1993; 78(1):14-21.
PMID: 7679660
PMC: 1421784.
Abnormal B cell function in haemophiliacs and their relationship with factor concentrates administration.
Brieva J, Sequi J, Zabay J, Pardo A, Campos A, de la Sen M
Clin Exp Immunol. 1985; 59(2):491-8.
PMID: 3919981
PMC: 1577117.
The Vancouver Lymphadenopathy-AIDS Study: 7. Clinical and laboratory features of 87 cases of primary HIV infection.
Boyko W, Schechter M, Craib K, Willoughby B, Douglas B, Sestak P
CMAJ. 1987; 137(2):109-13.
PMID: 3647808
PMC: 1492614.
Interactions of viruses with the immune system.
Mims C
Clin Exp Immunol. 1986; 66(1):1-16.
PMID: 3542314
PMC: 1542649.
The Vancouver Lymphadenopathy-AIDS Study: 5. Antecedent behavioural, clinical and laboratory findings in patients with AIDS and HIV-seropositive controls.
Boyko W, Schechter M, Craib K, Constance P, Nitz R, Fay S
CMAJ. 1986; 135(8):881-7.
PMID: 3463386
PMC: 1491496.
B-cell activation in HIV infection: relationship of spontaneous immunoglobulin secretion to various immunological parameters.
Mizuma H, Litwin S, Zolla-Pazner S
Clin Exp Immunol. 1988; 71(3):410-6.
PMID: 3260155
PMC: 1541680.
Molecular biology and immunology of cytomegalovirus.
Griffiths P, Grundy J
Biochem J. 1987; 241(2):313-24.
PMID: 3036059
PMC: 1147564.
DOI: 10.1042/bj2410313.
Synergistic activation of cells by Epstein-Barr virus and B-cell growth factor.
Hutt-Fletcher L
J Virol. 1987; 61(3):774-81.
PMID: 3027404
PMC: 254019.
DOI: 10.1128/JVI.61.3.774-781.1987.
Detection by monoclonal antibodies of an early membrane protein induced by Epstein-Barr virus.
Balachandran N, PITTARI J, Hutt-Fletcher L
J Virol. 1986; 60(2):369-75.
PMID: 3021971
PMC: 288902.
DOI: 10.1128/JVI.60.2.369-375.1986.
Enhancive and suppressive effects of cytomegalovirus on human lymphocyte responses in vitro.
Wahren B, Ljungman P, Paulin T, Ringden O
J Virol. 1986; 58(3):909-13.
PMID: 3009895
PMC: 252999.
DOI: 10.1128/JVI.58.3.909-913.1986.
Human immune responses to herpes simplex virus, varicella-zoster and cytomegalovirus in vitro.
Williamson S, Parish N, Chambers J, Knight R
Immunology. 1986; 57(3):437-42.
PMID: 3007334
PMC: 1453829.
The immunology of cytomegalovirus infection.
Sissons J
J R Coll Physicians Lond. 1986; 20(1):40-4.
PMID: 3003351
PMC: 5371131.
Modification of Epstein-Barr virus replication by tunicamycin.
Hutt-Fletcher L, Balachandran N, Leblanc P
J Virol. 1986; 57(1):117-23.
PMID: 3001337
PMC: 252705.
DOI: 10.1128/JVI.57.1.117-123.1986.